https://www.selleckchem.com/pr....oducts/20-hydroxyecd
non-alcoholic fatty liver (AUROC 0.87; p less then 0.0001). For the validation cohort, significance was attained for homozygous for PNPLA3 allele c.444C (AUROC 0.63; p less then 0.05). Combining adiponectin with specific serum lipids improved the assay performance (AUROC 0.80; p less then 0.0001). For the validation cohort, IGF-1 was lower with advanced fibrosis (AUROC 0.67, p less then 0.05), but combination with international normalized ratio (INR) and ferritin increased the assay performance (AUROC 0.81; p less then 0.01).
Like
Comment
Share
